−60 KRW
−4.49 B KRW
7.32 B KRW
4.88 M
About PANGEN BIOTECH INC.
Sector
Industry
Headquarters
Suwon-si
Website
Founded
2010
ISIN
KR7222110009
FIGI
BBG00B9WQHZ1
PanGen Biotech, Inc. engages in the production and sales of biopharmaceuticals. Its products include biosimilar erythropoietin (EPO), recombinant Factor VIII, biosimilar Aflibercept, recombinant anti-SFTSV Ab, and biosimilar G-CSF. The company was founded on January 29, 2010 and is headquartered in Suwon-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 222110 is 5,840 KRW — it has increased by 3.55% in the past 24 hours. Watch PANGEN BIOTECH INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PANGEN BIOTECH INC. stocks are traded under the ticker 222110.
222110 stock has risen by 11.88% compared to the previous week, the month change is a −4.42% fall, over the last year PANGEN BIOTECH INC. has showed a −11.38% decrease.
222110 reached its all-time high on Mar 11, 2016 with the price of 25,700 KRW, and its all-time low was 3,750 KRW and was reached on Aug 6, 2024. View more price dynamics on 222110 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
222110 stock is 5.14% volatile and has beta coefficient of −0.31. Track PANGEN BIOTECH INC. stock price on the chart and check out the list of the most volatile stocks — is PANGEN BIOTECH INC. there?
Today PANGEN BIOTECH INC. has the market capitalization of 72.75 B, it has increased by 9.90% over the last week.
Yes, you can track PANGEN BIOTECH INC. financials in yearly and quarterly reports right on TradingView.
222110 net income for the last quarter is 1.19 B KRW, while the quarter before that showed 200.50 M KRW of net income which accounts for 492.67% change. Track more PANGEN BIOTECH INC. financial stats to get the full picture.
No, 222110 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 71.00 employees. See our rating of the largest employees — is PANGEN BIOTECH INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PANGEN BIOTECH INC. EBITDA is 929.03 M KRW, and current EBITDA margin is −44.59%. See more stats in PANGEN BIOTECH INC. financial statements.
Like other stocks, 222110 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PANGEN BIOTECH INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PANGEN BIOTECH INC. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PANGEN BIOTECH INC. stock shows the buy signal. See more of PANGEN BIOTECH INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.